Functionality and Neurocognition in Patients With Bipolar Disorder After a Physical-exercise Program (FINEXT-BD Study)
NCT04400630, Not applicable, Unknown, Bioaraba Health Research Institute
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Functionality and Neurocognition in Patients With Bipolar Disorder After a Physical-exercise Program (FINEXT-BD Study) | ClinicalTrials.gov |
| NCT number | NCT04400630 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 80 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Bioaraba Health Research Institute | ClinicalTrials.gov |
| Conditions | Bipolar Disorder | ClinicalTrials.gov |
| Interventions | Physical exercise | ClinicalTrials.gov |
| First posted | 2020-05-22 | ClinicalTrials.gov |
| Last updated | 2020-09-16 | ClinicalTrials.gov |
Registered outcomes 64
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Patient Functionality measured through the scale FAST (4 months) | Change at the end of the training period (4 months) | The Functioning Assessment Short Test is a brief instrument designed to assess functional impairment in severe mental disorders. The 24 items of the scale cover six specific areas of functioning: autonomy, occupational functioning, cognitive functioning, financial issues, interpersonal relationships, and leisure time. | ClinicalTrials.gov |
| Primary | Patient Functionality measured through the scale FAST (10 months) | Changes after 10 months | The Functioning Assessment Short Test is a brief instrument designed to assess functional impairment in severe mental disorders. The 24 items of the scale cover six specific areas of functioning: autonomy, occupational functioning, cognitive functioning, financial issues, interpersonal relationships, and leisure time. | ClinicalTrials.gov |
| Primary | Patient Functionality measured through the scale GAF (4 months) | Change at the end of the training period (4 months) | Global Assessment of Functioning (GAF):This scale evaluates with a score from 0 to 100 the level of functioning and the severity of the patient's symptoms, the higher values corresponding to better overall functionality. | ClinicalTrials.gov |
| Primary | Patient Functionality measured through the scale GAF (10 months) | Changes after 10 months | Global Assessment of Functioning (GAF):This scale evaluates with a score from 0 to 100 the level of functioning and the severity of the patient's symptoms, the higher values corresponding to better overall functionality. | ClinicalTrials.gov |
| Primary | Patient Functionality measured through the Strauss-Carpenter scale (4 months) | Change at the end of the training period (4 months) | Strauss-Carpenter scale consists of four items rated from 0 to 4 on a Likert-type scale and yields a total score that is calculated by the addition of all item scores: the higher the score, the better is the prognosis. | ClinicalTrials.gov |
| Primary | Patient Functionality measured through the Strauss-Carpenter scale (10) months) | Changes after 10 months | Strauss-Carpenter scale consists of four items rated from 0 to 4 on a Likert-type scale and yields a total score that is calculated by the addition of all item scores: the higher the score, the better is the prognosis. | ClinicalTrials.gov |
| Secondary | TrkB-FL (4 months) | Change at the end of the training period (4 months) | Expression of BDNF: TrkB-FL | ClinicalTrials.gov |
| Secondary | TrkB-FL (10 months) | Changes after 10 months | Expression of BDNF: TrkB-FL | ClinicalTrials.gov |
| Secondary | TrkB-T (4 months) | Change at the end of the training period (4 months) | Expression of BDNF:TrkB-T | ClinicalTrials.gov |
| Secondary | TrkB-T (10 months) | Changes after 10 months | Expression of BDNF:TrkB-T | ClinicalTrials.gov |
| Secondary | BDNF (4 months) | Change at the end of the training period (4 months) | Peripheral BDNF levels | ClinicalTrials.gov |
| Secondary | BDNF (10 months) | Changes after 10 months | Peripheral BDNF levels | ClinicalTrials.gov |
| Secondary | Presence of depressive symptoms (4 months) | Change at the end of the training period (4 months) | Hamilton Depression Scale (HDRS-21) | ClinicalTrials.gov |
| Secondary | Presence of depressive symptoms (10 months) | Changes after 10 months | Hamilton Depression Scale (HDRS-21) | ClinicalTrials.gov |
| Secondary | VO2Peak in CPET (4 months) | Change at the end of the training period (4 months) | Value of VO2Peak (L min-1) in cardiopulmonary exercise test (CPET) | ClinicalTrials.gov |
| Secondary | VO2Peak in CPET (10 months) | Changes after 10 months | Value of VO2Peak (L min-1) in cardiopulmonary exercise test (CPET) | ClinicalTrials.gov |
| Secondary | Relative VO2Peak in CPET (4 months) | Change at the end of the training period (4 months) | Value of relative VO2Peak (mL kg-1 min-1) in cardiopulmonary exercise test (CPET) | ClinicalTrials.gov |
| Secondary | Relative VO2Peak in CPET (10 months) | Changes after 10 months | Value of relative VO2Peak (mL kg-1 min-1) in cardiopulmonary exercise test (CPET) | ClinicalTrials.gov |
| Secondary | METs in CPET (4 months) | Change at the end of the training period (4 months) | Value of metabolic equivalents in cardiopulmonary exercise test (CPET) | ClinicalTrials.gov |
| Secondary | METs in CPET (10 months) | Changes after 10 months | Value of metabolic equivalents in cardiopulmonary exercise test (CPET) | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 33240125 | DERIVED | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Card Sorting Test (Berg) | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Verbal Learning | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)